Digestive Diseases and Sciences

, Volume 48, Issue 3, pp 488–497 | Cite as

Effect of Altering Gastric Emptying on Postprandial Plasma Glucose Concentrations Following a Physiologic Meal in Type-II Diabetic Patients

  • Sutep Gonlachanvit
  • Chia-Wen Hsu
  • Guenther H. Boden
  • Linda C. Knight
  • Alan H. Maurer
  • Robert S. Fisher
  • Henry P. Parkman
Article

Abstract

The purpose of this study was to determine the effects of altering gastric emptying on postprandial plasma glucose concentration after a physiologic meal in patients with type II diabetes mellitus (T II DM). Nine T II DM patients underwent a double-blind, randomized, three-way crossover study, receiving erythromycin 200 mg, morphine 8 mg, or normal saline (placebo) intravenously prior to ingestion of a radiolabeled, dual-isotope, solid–liquid meal. Gastric emptying of solids and liquids and serial plasma glucose, glucagon, and serum insulin concentrations were measured at baseline and for 5 hr after meal ingestion. Erythromycin accelerated and morphine delayed solid- and liquid-phase gastric emptying compared to placebo (P < 0.05). During the first hour, the postprandial plasma glucose concentrations were higher after erythromycin (P < 0.05) and lower after morphine (P < 0.05) compared to placebo. The peak postprandial plasma glucose concentration was higher after erythromycin (P = 0.05) and lower after morphine (P < 0.05) compared to placebo. In conclusion, pharmacologic acceleration of gastric emptying resulted in higher postprandial glucose concentrations, while delaying gastric emptying resulted in lower postprandial glucose concentrations after a physiologic meal in T II DM. These results suggest that administration of opiate analgesics or prokinetic agents to diabetic patients may alter glucose control. Modifying gastric emptying may be helpful in achieving glucose control in T II DM.

gastric emptying diabetes mellitus glucose tolerance erythromycin morphine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993Google Scholar
  2. 2.
    Dagogo-Jack S, Santiago JV: Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 157:1802-1817, 1997Google Scholar
  3. 3.
    Dinneen S, Gerich J, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707-713, 1992Google Scholar
  4. 4.
    Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177-194, 2002Google Scholar
  5. 5.
    Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, Tattersall RB: Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40:82-88, 1997Google Scholar
  6. 6.
    Phillips WT, Schwartz JG, McMahan CA: Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying. Dig Dis Sci 38:51-58, 1993Google Scholar
  7. 7.
    Phillips WT, Schwartz JG: Decelerating gastric emptying: therapeutic possibilities in type 2 diabetes. Diabet Med 13:S44-S48, 1996Google Scholar
  8. 8.
    Nauck M: Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes. Diabet Med 13:S39-S43, 1996Google Scholar
  9. 9.
    Ray TK, Mansell KM, Knight LC, Malmud LS, Owen OE, Boden G: Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr 37:376-381, 1983Google Scholar
  10. 10.
    Torsdottir I, Alpsten M, Holm G, Sandberg AS, Tolli J: A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes. J Nutr 121:795-799, 1991Google Scholar
  11. 11.
    Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, Muls E, Bouillon R: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 322:1028-1031, 1990Google Scholar
  12. 12.
    Sullivan SN, Lee MG, Bloom SR, Lamki L, Dupre J: Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motility. Diabetes 35:324-328, 1986Google Scholar
  13. 13.
    Maurer AH, Knight LC, Charkes ND, Vitti RA, Krevsky B, Fisher RS, Siegel JA: Comparison of left anterior oblique and geometric mean gastric emptying. J Nucl Med 32:2176-2180, 1991Google Scholar
  14. 14.
    Winer BJ, Brown DR, Michels KM: Statistical Principles in Experimental Design, 3rd ed. New York, McGraw-Hill, 1991, pp 158-166Google Scholar
  15. 15.
    Schwartz JG, Green GM, Guan D, McMahan CA, Phillips WT: Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 19:468-471, 1996Google Scholar
  16. 16.
    Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 109:755-765, 1995Google Scholar
  17. 17.
    Phillips WT, Schwartz JG, McMahan CA: Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 33:1496-1500, 1992Google Scholar
  18. 18.
    Kolterman OG, Gottlieb A, Moyses C, Colburn W: Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18:1179-1182, 1995Google Scholar
  19. 19.
    Thompson RG, Peterson J, Gottlieb A, Mullane J: Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial. Diabetes 46:632-636, 1997Google Scholar
  20. 20.
    Thompson RG, Gottlieb A, Organ K, Koda J, Kisicki J, Kolterman OG: Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes. Diabet Med 14:547-555, 1997Google Scholar
  21. 21.
    Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ: Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342:1392-1398, 2000Google Scholar
  22. 22.
    Shiba Y, Mizumoto A, Satoh M, Inui A, Itoh Z, Omura S: Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs, Gastroenterology 110:241-250, 1996Google Scholar
  23. 23.
    Jones KL, Berry M, Kong M-F, Kwiater MA, Samsom M, Horowitz M: Hyperglycemia attenutates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 22:339-344, 1999Google Scholar
  24. 24.
    Melga P, Mansi C, Ciuchi E, Giusti R, Sciaba L, Prando R: Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 20:55-58, 1997Google Scholar
  25. 25.
    Ueno N, Inui A, Asakawa A, Takao F, Tani S, Komatsu Y, Itoh Z, Kasuga M: Erythromycin improves glycaemic control in patients with Type II diabetes mellitus. Diabetologia 43:411-415, 2000Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • Sutep Gonlachanvit
  • Chia-Wen Hsu
  • Guenther H. Boden
  • Linda C. Knight
  • Alan H. Maurer
  • Robert S. Fisher
  • Henry P. Parkman

There are no affiliations available

Personalised recommendations